Sprint Bioscience AB (publ) (FRA:5JA1)

Sprint Bioscience AB Revenue

Sprint Bioscience AB had revenue of 5.27M SEK in the quarter ending September 30, 2025, a decrease of -64.42%. This brings the company's revenue in the last twelve months to 49.76M, down -20.02% year-over-year. In the year 2024, Sprint Bioscience AB had annual revenue of 66.14M with 27.97% growth.

• Revenue (ttm): 49.76M SEK
• Revenue Growth: -20.02%
• P/S Ratio: 3.32
• Revenue / Employee: 1.31M SEK
• Employees: 38
• Market Cap: 15.04M EUR

Revenue Chart

* This company reports financials in SEK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	66.14M	14.46M	27.97%
Dec 31, 2023	51.69M	51.60M	62,171.08%
Dec 31, 2022	83.00K	-34.95M	-99.76%
Dec 31, 2021	35.03M	15.83M	82.49%
Dec 31, 2020	19.20M	-14.62M	-43.23%